NRIX
Price
$16.83
Change
+$0.48 (+2.94%)
Updated
Dec 3 closing price
Capitalization
1.71B
76 days until earnings call
Intraday BUY SELL Signals
ORIC
Price
$10.98
Change
+$0.33 (+3.10%)
Updated
Dec 3 closing price
Capitalization
1.07B
110 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRIX vs ORIC

Header iconNRIX vs ORIC Comparison
Open Charts NRIX vs ORICBanner chart's image
Nurix Therapeutics
Price$16.83
Change+$0.48 (+2.94%)
Volume$1.59M
Capitalization1.71B
Oric Pharmaceuticals
Price$10.98
Change+$0.33 (+3.10%)
Volume$1.04M
Capitalization1.07B
NRIX vs ORIC Comparison Chart in %
NRIX
Daily Signal:
Gain/Loss:
ORIC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NRIX vs. ORIC commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Hold and ORIC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (NRIX: $16.35 vs. ORIC: $10.65)
Brand notoriety: NRIX and ORIC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 52% vs. ORIC: 72%
Market capitalization -- NRIX: $1.71B vs. ORIC: $1.07B
NRIX [@Biotechnology] is valued at $1.71B. ORIC’s [@Biotechnology] market capitalization is $1.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 0 FA rating(s) are green whileORIC’s FA Score has 1 green FA rating(s).

  • NRIX’s FA Score: 0 green, 5 red.
  • ORIC’s FA Score: 1 green, 4 red.
According to our system of comparison, both NRIX and ORIC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 4 TA indicator(s) are bullish while ORIC’s TA Score has 3 bullish TA indicator(s).

  • NRIX’s TA Score: 4 bullish, 4 bearish.
  • ORIC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than ORIC.

Price Growth

NRIX (@Biotechnology) experienced а -3.82% price change this week, while ORIC (@Biotechnology) price change was -8.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

NRIX is expected to report earnings on Feb 18, 2026.

ORIC is expected to report earnings on Mar 24, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($1.71B) has a higher market cap than ORIC($1.07B). ORIC YTD gains are higher at: 31.970 vs. NRIX (-13.217). ORIC has higher annual earnings (EBITDA): -148.48M vs. NRIX (-248.7M). NRIX has more cash in the bank: 429M vs. ORIC (283M). ORIC has less debt than NRIX: ORIC (3.27M) vs NRIX (56.5M). NRIX has higher revenues than ORIC: NRIX (83.7M) vs ORIC (0).
NRIXORICNRIX / ORIC
Capitalization1.71B1.07B160%
EBITDA-248.7M-148.48M167%
Gain YTD-13.21731.970-41%
P/E RatioN/AN/A-
Revenue83.7M0-
Total Cash429M283M152%
Total Debt56.5M3.27M1,726%
TECHNICAL ANALYSIS
Technical Analysis
NRIXORIC
RSI
ODDS (%)
Bearish Trend 7 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
78%
Momentum
ODDS (%)
Bullish Trend 7 days ago
81%
Bearish Trend 7 days ago
80%
MACD
ODDS (%)
Bullish Trend 7 days ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
79%
Bearish Trend 7 days ago
84%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 16 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
85%
Bullish Trend 7 days ago
71%
Aroon
ODDS (%)
Bullish Trend 7 days ago
74%
Bearish Trend 7 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
NRIX
Daily Signal:
Gain/Loss:
ORIC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLMIX30.44N/A
N/A
Harding Loevner International Eq Instl
MXMTX11.21N/A
N/A
Empower Small Cap Growth Investor
ARRZX14.66N/A
N/A
AMG River Road Focused Absolute Value Z
AWWIX15.94N/A
N/A
CIBC Atlas International Growth Instl
MNSQX24.07N/A
N/A
Invesco Main Street Small Cap R5

ORIC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with ERAS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
-4.48%
ERAS - ORIC
46%
Loosely correlated
-3.50%
KYMR - ORIC
45%
Loosely correlated
-3.80%
ELVN - ORIC
45%
Loosely correlated
+3.68%
NRIX - ORIC
45%
Loosely correlated
-3.31%
NUVL - ORIC
43%
Loosely correlated
-1.37%
More